Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants.

Acton EK, Willis AW, Gelfand MA, Kasner SE.

Pharmacoepidemiol Drug Saf. 2019 Sep 13. doi: 10.1002/pds.4896. [Epub ahead of print]

PMID:
31517414
2.

Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes.

Hamedani AG, VanderBeek BL, Willis AW.

Ophthalmic Epidemiol. 2019 Aug;26(4):279-285. doi: 10.1080/09286586.2019.1611879. Epub 2019 May 7.

PMID:
31062638
3.

The use of psychological methodologies in cardiovascular disease interventions promoting a Mediterranean style diet: A systematic review.

Willis AW, Brown ON, Greene MW.

Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):325-333. doi: 10.1016/j.numecd.2018.12.011. Epub 2019 Jan 12.

PMID:
30777308
4.

State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.

Mantri S, Fullard ME, Beck J, Willis AW.

NPJ Parkinsons Dis. 2019 Jan 24;5:1. doi: 10.1038/s41531-019-0074-8. eCollection 2019.

5.

Readmission after seizure discharge in a nationally representative sample.

Blank LJ, Crispo JAG, Thibault DP, Davis KA, Litt B, Willis AW.

Neurology. 2018 Dec 21. pii: 10.1212/WNL.0000000000006746. doi: 10.1212/WNL.0000000000006746. [Epub ahead of print]

PMID:
30578373
6.

Sociodemographic Factors Associated With Hospital Care for Pediatric Migraine: A National Study Using the Kids' Inpatient Dataset.

Recober A, Patel PB, Thibault DP, Hill AW, Kaiser EA, Willis AW.

Pediatr Neurol. 2019 Feb;91:34-40. doi: 10.1016/j.pediatrneurol.2017.10.023. Epub 2018 Feb 1.

PMID:
30578049
7.

Understanding nationwide readmissions after thyroid surgery.

Rios-Diaz AJ, Zheng R, Thibault DP, Crispo JAG, Willis AW, Willis AI.

Surgery. 2019 Feb;165(2):423-430. doi: 10.1016/j.surg.2018.09.007. Epub 2018 Dec 10.

PMID:
30545657
8.

Adverse Drug Events as a Reason for Adult Hospitalization: A Nationwide Readmission Study.

Crispo JAG, Thibault DP, Willis AW.

Ann Pharmacother. 2019 Jun;53(6):557-566. doi: 10.1177/1060028018818571. Epub 2018 Dec 10.

PMID:
30525918
9.

Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients.

Hill CE, Blank LJ, Thibault D, Davis KA, Dahodwala N, Litt B, Willis AW.

Neurology. 2019 Jan 1;92(1):e9-e18. doi: 10.1212/WNL.0000000000006689. Epub 2018 Nov 30.

PMID:
30504428
10.

Association between medication-related adverse events and non-elective readmission in acute ischemic stroke.

Crispo JAG, Thibault DP, Fortin Y, Krewski D, Willis AW.

BMC Neurol. 2018 Nov 19;18(1):192. doi: 10.1186/s12883-018-1195-0.

11.

Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.

Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW.

JAMA Neurol. 2019 Jan 1;76(1):41-49. doi: 10.1001/jamaneurol.2018.2820.

PMID:
30285047
12.

β2-adrenoreceptor medications and risk of Parkinson disease.

Searles Nielsen S, Gross A, Camacho-Soto A, Willis AW, Racette BA.

Ann Neurol. 2018 Nov;84(5):683-693. doi: 10.1002/ana.25341. Epub 2018 Oct 30.

PMID:
30225948
13.

Inpatient care for stiff person syndrome in the United States: a nationwide readmission study.

Crispo JAG, Thibault DP, Fortin Y, Willis AW.

J Clin Mov Disord. 2018 Aug 6;5:5. doi: 10.1186/s40734-018-0071-9. eCollection 2018.

14.

Readmissions After Mechanical Thrombectomy for Acute Ischemic Stroke in the United States: A Nationwide Analysis.

Ramchand P, Thibault DP, Crispo JA, Levine J, Hurst R, Mullen MT, Kasner S, Willis AW.

J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2632-2640. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.035. Epub 2018 Jul 2.

PMID:
30042034
15.

Immunosuppressants and risk of Parkinson disease.

Racette BA, Gross A, Vouri SM, Camacho-Soto A, Willis AW, Searles Nielsen S.

Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580. eCollection 2018 Jul.

16.

Prevalence of Parkinson's disease across North America.

Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM; Parkinson’s Foundation P4 Group.

NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.

17.

Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.

Fullard ME, Willis AW.

Neurology. 2018 Apr 24;90(17):813. doi: 10.1212/WNL.0000000000005367. No abstract available.

PMID:
29686121
18.

Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists.

Elson MJ, Stevenson EA, Feldman BA, Lim J, Beck CA, Beran DB, Schmidt PN, Biglan KM, Simone R, Willis AW, Dorsey ER, Boyd CM.

Telemed J E Health. 2018 Sep;24(9):722-724. doi: 10.1089/tmj.2017.0210. Epub 2018 Jan 3.

PMID:
29297769
19.

Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability.

Fullard ME, Thibault DP, Todaro V, Foster S, Katz L, Morgan R, Kern DS, Schwalb JM, Urrea Mendoza E, Dahodwala N, Shulman L, Willis AW.

Parkinsonism Relat Disord. 2018 Mar;48:45-50. doi: 10.1016/j.parkreldis.2017.12.012. Epub 2017 Dec 14.

20.

Sex disparities in access to caregiving in Parkinson disease.

Dahodwala N, Shah K, He Y, Wu SS, Schmidt P, Cubillos F, Willis AW.

Neurology. 2018 Jan 2;90(1):e48-e54. doi: 10.1212/WNL.0000000000004764. Epub 2017 Dec 1.

PMID:
29196580
21.

Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.

Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS.

Mov Disord. 2017 Nov;32(11):1636-1640. doi: 10.1002/mds.27127. Epub 2017 Sep 14.

22.

A predictive model to identify Parkinson disease from administrative claims data.

Searles Nielsen S, Warden MN, Camacho-Soto A, Willis AW, Wright BA, Racette BA.

Neurology. 2017 Oct 3;89(14):1448-1456. doi: 10.1212/WNL.0000000000004536. Epub 2017 Sep 1.

23.

Utilization of rehabilitation therapy services in Parkinson disease in the United States.

Fullard ME, Thibault DP, Hill A, Fox J, Bhatti DE, Burack MA, Dahodwala N, Haberfeld E, Kern DS, Klepitskava OS, Urrea-Mendoza E, Myers P, Nutt J, Rafferty MR, Schwalb JM, Shulman LM, Willis AW; Parkinson Study Group Healthcare Outcomes and Disparities Working Group.

Neurology. 2017 Sep 12;89(11):1162-1169. doi: 10.1212/WNL.0000000000004355. Epub 2017 Aug 23.

24.

National randomized controlled trial of virtual house calls for Parkinson disease.

Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W; Connect.Parkinson Investigators.

Neurology. 2017 Sep 12;89(11):1152-1161. doi: 10.1212/WNL.0000000000004357. Epub 2017 Aug 16.

25.

Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study.

Mammen JR, Elson MJ, Java JJ, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Dorsey ER.

Telemed J E Health. 2018 Apr;24(4):255-267. doi: 10.1089/tmj.2017.0119. Epub 2017 Aug 1.

PMID:
28787250
26.

Progressive rural-urban disparity in acute stroke care.

Gonzales S, Mullen MT, Skolarus L, Thibault DP, Udoeyo U, Willis AW.

Neurology. 2017 Jan 31;88(5):441-448. doi: 10.1212/WNL.0000000000003562. Epub 2017 Jan 4.

27.

Nutrition knowledge and Mediterranean diet adherence in the southeast United States: Validation of a field-based survey instrument.

Bottcher MR, Marincic PZ, Nahay KL, Baerlocher BE, Willis AW, Park J, Gaillard P, Greene MW.

Appetite. 2017 Apr 1;111:166-176. doi: 10.1016/j.appet.2016.12.029. Epub 2016 Dec 23.

PMID:
28017910
28.

Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Willis AW, Thibault DP, Schmidt PN, Dorsey ER, Weintraub D.

Mov Disord. 2016 Dec;31(12):1810-1819. doi: 10.1002/mds.26832.

29.

Prevalence and Correlates of Anti-Parkinson Drug Use in a Nationally Representative Sample.

Dahodwala N, Willis AW, Li P, Doshi JA.

Mov Disord Clin Pract. 2016 Aug 22;4(3):335-341. doi: 10.1002/mdc3.12422. eCollection 2017 May-Jun.

30.

Patient safety events in hospital care of individuals with epilepsy.

Mendizabal A, Thibault DP, Willis AW.

Epilepsia. 2016 Aug;57(8):1301-9. doi: 10.1111/epi.13440. Epub 2016 Jun 28.

31.

Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease.

Safarpour D, Willis AW.

Am J Alzheimers Dis Other Demen. 2016 Nov;31(7):585-594. Epub 2016 Jun 13. Review.

PMID:
27295974
32.

Hospital care for mental health and substance abuse in children with epilepsy.

Thibault DP, Mendizabal A, Abend NS, Davis KA, Crispo J, Willis AW.

Epilepsy Behav. 2016 Apr;57(Pt A):161-166. doi: 10.1016/j.yebeh.2016.01.031. Epub 2016 Mar 7.

33.

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.

Crispo JA, Willis AW, Thibault DP, Fortin Y, Hays HD, McNair DS, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison DR, Krewski D.

PLoS One. 2016 Mar 3;11(3):e0150621. doi: 10.1371/journal.pone.0150621. eCollection 2016.

34.

National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.

Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W.

Telemed J E Health. 2016 Jul;22(7):590-8. doi: 10.1089/tmj.2015.0191. Epub 2016 Feb 17.

35.

Demographics, disparities, and outcomes in substernal goiters in the United States.

Moten AS, Thibault DP, Willis AW, Willis AI.

Am J Surg. 2016 Apr;211(4):703-9. doi: 10.1016/j.amjsurg.2015.11.022. Epub 2016 Jan 6.

PMID:
26813846
36.

Erratum To: Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.

Achey MA, Beck CA, Beran DB, Boyd CM, Schmidt PN, Willis AW, Riggare SS, Simone RB, Biglan KM, Dorsey ER.

Trials. 2016 Jan 5;17:7. doi: 10.1186/s13063-015-0984-7. No abstract available.

37.

Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease.

Crispo JAG, Willis AW, Thibault DP, Fortin Y, Emons M, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison D, Krewski D.

Mov Disord Clin Pract. 2015 Dec 24;3(3):257-267. doi: 10.1002/mdc3.12286. eCollection 2016 May-Jun.

38.

Using Administrative Data to Examine Health Disparities and Outcomes in Neurological Diseases of the Elderly.

Willis AW.

Curr Neurol Neurosci Rep. 2015 Nov;15(11):75. doi: 10.1007/s11910-015-0595-4. Review.

PMID:
26423637
39.

Nursing home and end-of-life care in Parkinson disease.

Safarpour D, Thibault DP, DeSanto CL, Boyd CM, Dorsey ER, Racette BA, Willis AW.

Neurology. 2015 Aug 4;85(5):413-9. doi: 10.1212/WNL.0000000000001715. Epub 2015 Jul 2.

40.

Physician response to a medication alert system in inpatients with levodopa-treated diseases.

Morris M, Willis AW, Searles Nielsen S, McCann F, Birke A, Racette BA.

Neurology. 2015 Aug 4;85(5):420-4. doi: 10.1212/WNL.0000000000001745. Epub 2015 Jun 19.

41.

Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

Crispo JA, Fortin Y, Thibault DP, Emons M, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison D, Willis AW, Krewski D.

Eur J Clin Pharmacol. 2015 Aug;71(8):1011-9. doi: 10.1007/s00228-015-1881-4. Epub 2015 Jun 18.

42.

Time to change the blind men and the elephant approach to Parkinson disease?

Racette BA, Willis AW.

Neurology. 2015 Jul 14;85(2):190-6. doi: 10.1212/WNL.0000000000001739. Epub 2015 Jun 12. Review.

43.

Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.

Achey MA, Beck CA, Beran DB, Boyd CM, Schmidt PN, Willis AW, Riggare SS, Simone RB, Biglan KM, Dorsey ER.

Trials. 2014 Nov 27;15:465. doi: 10.1186/1745-6215-15-465. Erratum in: Trials. 2016;17:7.

44.

Disparities in deep brain stimulation surgery among insured elders with Parkinson disease.

Barrett M, Yan G, Abbott RD, Willis AW.

Neurology. 2014 Oct 28;83(18):1684-5. doi: 10.1212/WNL.0000000000000974. No abstract available.

PMID:
25349276
45.

Feeding tube placement in stroke patients: urgent need for health services and outcomes research.

Willis AW, Williams L, Mullen MT.

Neurology. 2014 Sep 2;83(10):870-1. doi: 10.1212/WNL.0000000000000759. Epub 2014 Aug 6. No abstract available.

PMID:
25098534
46.

Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Harris-Hayes M, Willis AW, Klein SE, Czuppon S, Crowner B, Racette BA.

J Bone Joint Surg Am. 2014 Feb 19;96(4):e27. doi: 10.2106/JBJS.L.01317.

47.

Disparities in deep brain stimulation surgery among insured elders with Parkinson disease.

Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA.

Neurology. 2014 Jan 14;82(2):163-71. doi: 10.1212/WNL.0000000000000017. Epub 2013 Dec 11.

48.

Parkinson disease in the elderly adult.

Willis AW.

Mo Med. 2013 Sep-Oct;110(5):406-10. Review.

49.

The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.

Dorsey ER, George BP, Leff B, Willis AW.

Neurology. 2013 May 21;80(21):1989-96. doi: 10.1212/WNL.0b013e318293e2ce. Epub 2013 Apr 24. Review.

50.

Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology.

Romeo S, Viaggi C, Di Camillo D, Willis AW, Lozzi L, Rocchi C, Capannolo M, Aloisi G, Vaglini F, Maccarone R, Caleo M, Missale C, Racette BA, Corsini GU, Maggio R.

Sci Rep. 2013;3:1395. doi: 10.1038/srep01395.

Supplemental Content

Loading ...
Support Center